Directed biosynthesis of fluorinated pseurotin A, synerazol and gliotoxin

Journal of Antibiotics

Volumn 57, Issue 11, 2004, Pages 748-754

  Igarashi, Yasuhiro ^a   Yabuta, Yukihiro ^a   Sekine, Akira ^a   Fuji, Kiyonaga ^b   Harada, Ken Ichi ^b   Oikawa, Tsutomu ^c,e   Sato, Mayumi ^c   Furumai, Tamotsu ^a   Oki, Toshikazu ^a,d  

^a TOYAMA PREFECTURAL UNIVERSITY   (Japan)

^b MEIJO UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d TAMAGAWA UNIVERSITY   (Japan)

^e KANAGAWA UNIVERSITY OF HUMAN SERVICES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

19 FLUOROSYNERAZOL; 20 FLUOROSYNERAZOL; ANTIBIOTIC AGENT; FLUORINE DERIVATIVE; FLUOROPHENYLALANINE; GLIOTOXIN; PHENYLALANINE; PSEUROTIN A; SYNERAZOL; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ANTIBIOTIC BIOSYNTHESIS; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; ASPERGILLUS FUMIGATUS TP F0196; BIOASSAY; CANCER CELL CULTURE; CHORIOALLANTOIS; CHROMATOGRAPHY; CYTOTOXICITY; DRUG ISOLATION; DRUG PURIFICATION; DRUG STRUCTURE; FLUORINATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SOLVENT EXTRACTION;

ASPERGILLUS FUMIGATUS;

EID: 10044251967     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.57.748     Document Type: Article

References (22)

1. BLOCH, P. & C. TAMM: Isolation and structure of pseurotin A, a microbial metabolite of Pseudeurotium ovalis STOLK with an unusual heterospirocyclic system. Helv. Chim. Acta 64: 304-315, 1981
2. WENKE, J.; H. ANKE & O. STERNER: Pseurotin A and 8-0- demethylpseurotin A from Aspergillus fumigatus and their inhibitory activities on chitin synthase. Biosci. Biotech. Biochem. 57: 961-964, 1993
3. KOMAGATA, D.; S. FUJITA, N. YAMASHITA, S. SAITO & T. MORINO: Novel neuritogenic activities of pseurotin A andpenicillic acid. J. Antibiotics 49: 958-959, 1996
4. ANDO, O.; H. SATAKE, M. NAKAJIMA, A. SATO, T. NAKAMURA, T. KINOSHITA, K. FURUYA & T. HANEISHI: Synerazol, a new antifungal antibiotic. J. Antibiotics 44: 382-389, 1991
5. VAN DER PYL, D.; J. INOKOSHI, K. SHIOMI, H. YANG, H. TAKESHIMA & S. ŌMURA: Inhibition of farneysyl-protein transferase by gliotoxin and acetylgliotoxin. J. Antibiotics 45: 1802-1805, 1992
6. MOHR, P. & C. TAMM: Biosynthesis of pseurotin A. Tetrahedron 37: 201-212, 1981
7. BOSE, A. K.; K. G. DAS, P. T. FUNKE, I. KUGAJEVSKY, O. P. SHUKLA, K. S. KHANCHANDANI & R. J. SUHADOLNIK: Biosynthetic studies on gliotoxin using stable isotopes and mass spectral methods. J. Am. Chem. Soc. 90: 1038-1041, 1968
8. ISONO, K.; P. F. CRAIN, T. J. ODIORNE, J. A. MCCLOSKEY & R. J. SUHADOLNIK: Biosynthesis of the 5-fluoropolyoxins, aberrant nucleoside antibiotics. J. Am. Chem. Soc. 95: 5788-5789, 1973
9. TOSCANO, L.; G. FIOREILLO, R. SPAGNOLI, L. CAPPELLETTI & G. ZANUSO: New fluorinated erythromycins obtained by mutasynthesis. J. Antibiotics 36: 1439-1450, 1983
10. 19F NMR spectroscopy. I. Fluorinated vulgamycins. J. Antibiotics 38: 1499-1505, 1985
11. 19F NMR spectroscopy. II. Fluorinated actinomycins. J. Antibiotics 38: 1625-1628, 1985
12. HOUCK, D. R.; J. ONDEYKA, D. L. ZINK, E. INAMINE, M. A. GOETZ & O. D. HENSENS: On the biosynthesis of asperlicin and the directed biosynthesis of analogs in Aspergillus alliaceus. J. Antibiotics 41: 882-891, 1988
13. CANNELL, R. J. P.; M. J. DAWSON, R. S. HALE, R. M. HALL, D. NOBLE, S. LYNNN, &L. TAYLOR: The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. IV. Preparation of fluorinated squalestatins by directed biosynthesis. J. Antibiotics 46: 1381-1389, 1993
14. LAM, K. S.; D. R. SCHROEDER, J. M. VEITCH, K. L. COLSON, J. A. MATSON, W. C. ROSE, T. W. DOYLE & S. FORENZA: Production, isolation and structure determination of novel fluoroindolocarbazoles from Saccharothrix aerocolonigenes ATCC 39243. J. Antibiotics 54: 1-9, 2001
15. TAKAHASHI, H.; M. ABE, T. SUGAWARA, K. TANAKA, Y. SAITO, S. FUJIMURA, M. SHIBUYA & Y. SATO: Clotrimazole, an imidazole antimycotic, is a potent inhibitor of angiogenesis. Jpn. J. Cancer Res. 89: 445-451, 1998
16. OIKAWA, T.; K. HIROTANI, O. NAKAMURA, K. SHUDO, A. HIRAGUN & T. IWAGUCHI: A highly potent anti-angiogenic activity of retinoids. Cancer Lett. 48: 157-162, 1989
17. 3 analogues. Eur. J. Pharmacol. 178: 247-250, 1990
18. OIKAWA, T.; T. SASAKI, M. NAKAMURA, M. SHIMAMURA, N. TANAHASHI, S. OMURA & K. TANAKA: The proteasome is involved in angiogenesis. Biochem. Biophys. Res. Commun. 246: 243-248, 1998
19. SIN, N.; L. MENG, H. AUTHC, & M. CREWS: Eponemycin analogues: syntheses and use as probes of angiogenesis. Bioorg. Med. Chem. 6: 1209-1217, 1998
20. DI NAPOLI, M. & F. PAPA: MLN-519 Millennium/PAION. Curr. Opin. Investig. Drugs 4: 333-341, 2003
21. IGARASHI, Y.; Y. YABUTA & T. FURUMAI: Determination of the absolute configuration of synerazol. J. Antibiotics 57: 537-540, 2004
22. ASAMI, Y.; H. KAKEYA, R. ONOSE, A. YOSHIDA, H. MATSUZAKI & H. OSADA: Azaspirene: a novel angiogenesis inhibitor containing a 1-oxa-7-azaspiro[4.4] non-2-ene-4,6-dione skeleton produced by the fungus Neosartorya sp. Org. Lett. 4: 2845-2848, 2002